Wealth Advisory Solutions’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$266K Hold
907
0.06% 114
2025
Q4
$318K Hold
907
0.07% 106
2025
Q3
$293K Hold
907
0.07% 114
2025
Q2
$353K Hold
907
0.09% 107
2025
Q1
$395K Hold
907
0.1% 99
2024
Q4
$335K Sell
907
-1
-0.1% -$418 0.09% 96
2024
Q3
$472K Hold
908
0.13% 87
2024
Q2
$492K Hold
908
0.13% 84
2024
Q1
$471K Buy
908
+158
+21% +$78.6K 0.12% 85
2023
Q4
$354K Sell
750
-158
-17% -$73.1K 0.12% 67
2023
Q3
$395K Buy
+908
New +$412K 0.08% 100
2023
Q2
Sell
-912
Closed -$419K 104
2023
Q1
$419K Hold
912
0.11% 88
2022
Q4
$468K Hold
912
0.13% 95
2022
Q3
$414K Sell
912
-490
-35% -$234K 0.11% 100
2022
Q2
$677K Buy
1,402
+221
+19% +$109K 0.17% 88
2022
Q1
$580K Buy
+1,181
New +$540K 0.12% 99
2021
Q3
$965K Buy
2,589
+265
+11% +$101K 0.21% 84
2021
Q2
$887K Buy
+2,324
New +$888K 0.21% 90

Other funds holding ELV

Wealth Advisory Solutions's ELV Position: Q1 2026 in Review

Wealth Advisory Solutions held its Elevance Health (ELV) position steady in Q1 2026 at 907 shares worth $266K. The position accounts for 0.06% of the portfolio, ranked #114.

Wealth Advisory Solutions first reported a position in ELV in Q2 2021 and has held it in 18 quarters since. The position peaked at $965K in Q3 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Wealth Advisory Solutions held 907 shares of Elevance Health worth $266K as of Q1 2026.
  • Wealth Advisory Solutions left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up 0.06% of Wealth Advisory Solutions's portfolio in Q1 2026, its #114 holding.
  • Wealth Advisory Solutions first reported a position in Elevance Health in Q2 2021 and has held it in 18 quarters since.
  • Wealth Advisory Solutions's Elevance Health position peaked at $965K in Q3 2021.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Wealth Advisory Solutions's 13F filing for Q1 2026, filed 22 Apr 2026.